Mycosis Fungoides of the Larynx

Edelson RL Kirkpatrick CH Shevach EM Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Ann Intern Med 1974; 80: 685–92

Weinstock MA Horm JW . Mycosis fungoides in the United States: Increasing incidence and descriptive epidemiology. JAMA 1988; 260: 42–6

Fischmann AB Bunn PA Guccione JG Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sezary syndrome. Cancer Treat Rep 1979; 63: 591–6

Bazin E. Lecons Sur le traitment des Maladies Chroniques en General Affections de la Peau en Particulier par l'Emploi Compare des eaux Minerales l'Hydrotherapie et des Moyens Pharmaceutiques. Paris: Adrien Delahaye, 1870: 425

Vonderheid EC Van Scott EJ Wallner PE Johnson WC . A 10 year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy. Cancer Treat Rep 1979; 63: 681

Worobec-Victor SM . Cutaneous T-cell lymphoma. N J Med 1989; 86: 395–9

Rappaport H Thomas LB . Mycosis fungoides: the pathology of extracutaneous involvement. Cancer 1974; 34: 1198–229

Suasville EA Eddy JL Makuck RW .Hisopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome: definition of these distinctive prognostic groups. Ann Intern Med 1988; 109: 372–82

Winkler CF Bunn PA . Cutaneous T-cell lymphoma: a review. Crit Rev Oncol Hematol 1983; 1: 49–92

Evans GE Dolziel KL . Mycosis fungoides with oral involvement. Int J Oral Maxillofac Surg 1987; 16: 634–7

Epstein EH Jr Levin KL Croft JD Lutzner MA . Mycosis fungoides. Survival, prognostic features, response to therapy, and autopsy findings. Medicine 1972; 15: 61–72

Hood AF Mark GJ Hunt JV . Lamygeal mycosis fungoides. Cancer 1979; 43: 1527–32

Agarwal MK Gupta S Gupta OP . Mycosis fungoides of the larynx. Asian Med J 1982; 294: 268–71

Ferlito A Gianfranco R. Laryngeal involvement by mycosis fungoides. Ann Otol Rhinol Laryngol 1986; 95: 275–7